StroMedix Receives $2,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e76d84f-71f6-470c-b265-b4660043b387&Preview=1 -
Date
1/25/2011 -
Company Name
StroMedix -
Mailing Address
One Canal Park Cambridge, MA 02141 -
Company Description
Stromedix is a clinical-stage biotechnology company committed to developing novel drugs to treat fibrotic organ failure. Stromedix will focus initially on chronic indications but plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer. The company plans to build its pipeline through both internal drug discovery and in-licensing. -
Website
http://www.stromedix.com -
Transaction Type
Debt -
Transaction Amount
$2,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
